Ourania Tatsis - 24 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2022
Net transactions value
-$665,215
Form type
4
Filing time
28 Feb 2022, 16:27:32 UTC
Previous filing
22 Feb 2022
Next filing
21 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $590,157 -2,590 -4.9% $227.86 50,514 24 Feb 2022 Direct
transaction VRTX Common Stock Sale $6,409 -28 -0.06% $228.88 50,486 25 Feb 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $17,730 -77 -0.15% $230.26 50,409 25 Feb 2022 Direct F1, F3, F4
transaction VRTX Common Stock Sale $26,562 -115 -0.23% $230.97 50,294 25 Feb 2022 Direct F1, F3, F5
transaction VRTX Common Stock Sale $20,167 -87 -0.17% $231.81 50,207 25 Feb 2022 Direct F1, F3, F6
transaction VRTX Common Stock Sale $4,190 -18 -0.04% $232.80 50,189 25 Feb 2022 Direct F1, F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $228.88 (range $228.39 to $229.36).
F3 Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $230.26 (range $229.50 to $230.48).
F5 Open market sales reported on this line occurred at a weighted average price of $230.97 (range $230.50 to $231.47).
F6 Open market sales reported on this line occurred at a weighted average price of $231.81 (range $231.52 to $232.31).
F7 Open market sales reported on this line occurred at a weighted average price of $232.80 (range $232.59 to $232.92).